SEC Form 3 · accession 0001209191-16-140979

ANTARES PHARMA, INC. · ATRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Keith E Muckenhirn

Officer — VP/Controller & Interim CFO

Period of report

Sep 4, 2016

Accepted (ET)

Sep 12, 2016 · 6:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001016169

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	50,000	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F1	$1.23	holding	—	—	—	Jan 16, 2010	Jan 15, 2017	Common Stock $0.01 par value per share	30,000	—	D
Stock Option (right to buy)^F1	$1.65	holding	—	—	—	May 10, 2010	May 9, 2017	Common Stock $0.01 par value per share	15,000	—	D
Stock Option (right to buy)^F1	$0.85	holding	—	—	—	May 14, 2011	May 13, 2018	Common Stock $0.01 par value per share	45,000	—	D
Stock Option (right to buy)^F1	$0.47	holding	—	—	—	Nov 12, 2011	Nov 11, 2018	Common Stock $0.01 par value per share	20,000	—	D
Stock Option (right to buy)^F1	$1.10	holding	—	—	—	Nov 11, 2012	Nov 11, 2019	Common Stock $0.01 par value per share	45,000	—	D
Stock Option (right to buy)^F1	$1.52	holding	—	—	—	Nov 11, 2013	Nov 10, 2020	Common Stock $0.01 par value per share	35,000	—	D
Stock Option (right to buy)^F1	$2.94	holding	—	—	—	May 17, 2015	May 16, 2022	Common Stock $0.01 par value per share	20,000	—	D
Stock Option (right to buy)^F1	$3.96	holding	—	—	—	May 22, 2016	May 22, 2023	Common Stock $0.01 par value per share	30,000	—	D
Stock Option (right to buy)^F2	$2.29	holding	—	—	—	—	Nov 19, 2024	Common Stock $0.01 par value per share	35,000	—	D
Stock Option (right to buy)^F3	$3.09	holding	—	—	—	—	May 29, 2024	Common Stock $0.01 par value per share	35,000	—	D
Stock Option (right to buy)^F4	$2.18	holding	—	—	—	—	May 28, 2025	Common Stock $0.01 par value per share	35,000	—	D
Stock Option (right to buy)^F5	$1.12	holding	—	—	—	—	Jun 2, 2026	Common Stock $0.01 par value per share	40,000	—	D

Explanation of responses

F1Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vested in equal quarterly installments over three years from the initial grant date. The exercisable date listed above represents the date the options became fully vested and exercisable.
F2Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on November 20, 2014 and are vesting in equal quarterly installments over three years from the initial grant date.
F3Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on May 29, 2014 and are vesting in equal quarterly installments over three years from the initial grant date.
F4Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on May 28, 2015 and are vesting in equal quarterly installments over three years from the initial grant date.
F5Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options were granted on June 2, 2016 and are vesting in equal quarterly installments over three years from the initial grant date.